-
1مؤتمر
المؤلفون: Andrey Kulikov (4871602), Elena Shipaeva (11258712), Anastasia Dmitrieva (11258715), Vera Batrak (267991), Georgy Shipunov (11258718), Colin Guy (3136320), Jill Smith (2694001), Ran Zhang (117374), Michael Zhang (196907), Jeff Duan (11258721), Anton Chestukhin (11258724), Sergei Barbashov (11258727), Mikhail Samsonov (11258730), Yan Lavrovsky (2390548)
مصطلحات موضوعية: Pharmacology, Basic Pharmacology, Clinical Pharmacology and Therapeutics, Clinical Pharmacy and Pharmacy Practice, Pharmaceutical Sciences, Pharmacogenomics, Toxicology (incl. Clinical Toxicology), Pharmacology and Pharmaceutical Sciences not elsewhere classified, cancer immunotherapy, monoclonal antibody, PD-L1, in vitro efficacy, animal models, therapeutic agent
-
2
المؤلفون: Andrey Kulikov, Anastasia Dmitrieva, Elena Shipaeva, Vera Batrak, Michael Zhang, Colin Guy, Mikhail Samsonov, Jeff Duan, Ran Zhang, Georgy Shipunov, Yan Lavrovsky, Jill Smith, Sergei Barbashov, Anton Chestukhin
المصدر: Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacologyمصطلحات موضوعية: PD-L1, Pharmacology, cancer immunotherapy, medicine.drug_class, Chemistry, medicine.medical_treatment, Cancer, RM1-950, Mixed lymphocyte reaction, Monoclonal antibody, medicine.disease, in vitro efficacy, Fusion protein, animal models, In vitro, Cancer immunotherapy, monoclonal antibody, In vivo, Atezolizumab, medicine, Pharmacology (medical), therapeutic agent, Therapeutics. Pharmacology, Original Research
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca5ccb0106709018fc75218482361d7dTest
https://doi.org/10.3389/fphar.2021.723038Test